A multi-omics approach reveals molecular alterations in the digestive gland of Mytilus galloprovincialis following fluoxetine exposure
Abstract
Antidepressant consumption has increased markedly in recent years, a trend further amplified by the COVID-19 pandemic. Among these compounds, fluoxetine (FLX), a selective serotonin reuptake inhibitor (SSRI), is one of the most widely prescribed worldwide. Although the effects of FLX on aquatic organisms are well documented, the molecular mechanisms underlying these effects remain insufficiently understood and are essential for a comprehensive assessment of its environmental impact. The present study investigated the molecular effects of FLX in the marine mussel Mytilus galloprovincialis. Mussels were exposed to a nominal concentration of FLX (3.1 µg/L) for 28 days with sampling on days 2, 7, 14, and 28. Molecular responses were characterized using a multi-omics approach. Transcriptomics, proteomics, and metabolomics were acquired from paired digestive gland samples (from the same individual) and subsequently integrated through data fusion modeling and pathway-enrichment analyses. Although molecular responses to FLX were relatively subtle, multi-omics integration revealed consistent modulation of pathways involved in cellular signaling, oxidative stress, energy metabolism, and MAPK pathways. These molecular responses were consistent with previously reported organism-level effects of FLX in mussels. Based on these findings, a putative Adverse Outcome Pathway (AOP) was proposed to link the molecular events identified in this study to individual effects previously reported in the literature. Overall, these findings highlight the value of multi-omics approaches for elucidating pharmaceutical effects in marine organisms and underscore the importance of integrating molecular data with organism-level observations to support AOP development.
Related
- Anthropogenic particles and legacy pollutants combined with transcriptomic and multi-biomarker responses for an integrated assessment of the health status of mussels Mytilus galloprovincialis in two locations of the Bay of Biscay
- Accurate determination of fluoxetine and its metabolites in Mediterranean mussel organs based on solid phase extraction clean-up and HPLC-HRMS
- Digging into Understudied Sediments: What Lumbriculus variegatus Reveals about Fluoxetine Exposure from the Cellular to the Individual Level.
- Psychotropic drugs in drinking water? A scoping review of evidence on diazepam and fluoxetine.
- Microplastics (PP, PE, PS, and PVC) Induce Structural and Functional Changes in Digestive Enzymes: Insights from Spectroscopic Approaches
BibTeX
@article{lemaire2026multiomics,
title = {{A multi-omics approach reveals molecular alterations in the digestive gland of Mytilus galloprovincialis following fluoxetine exposure}},
author = {Etienne Lemaire and Elena Gomez and Julien Boccard and Jean Armengaud and Eider Bilbao and Aurélie Escande and Mélodie Kielbasa and Thibaut Dumas and Zoé Arrigoni and Mikel Aguirre and Gorka Arribas and Miren Cajaraville and Frédérique Courant},
journal = {Aquatic Toxicology},
year = {2026},
month = oct,
doi = {10.1016/j.aquatox.2026.108027},
url = {https://hal.science/hal-05770606v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - A multi-omics approach reveals molecular alterations in the digestive gland of Mytilus galloprovincialis following fluoxetine exposure
AU - Etienne Lemaire
AU - Elena Gomez
AU - Julien Boccard
AU - Jean Armengaud
AU - Eider Bilbao
AU - Aurélie Escande
AU - Mélodie Kielbasa
AU - Thibaut Dumas
AU - Zoé Arrigoni
AU - Mikel Aguirre
AU - Gorka Arribas
AU - Miren Cajaraville
AU - Frédérique Courant
PY - 2026
DA - 2026/10/02
JO - Aquatic Toxicology
DO - 10.1016/j.aquatox.2026.108027
UR - https://hal.science/hal-05770606v1
AB - Antidepressant consumption has increased markedly in recent years, a trend further amplified by the COVID-19 pandemic. Among these compounds, fluoxetine (FLX), a selective serotonin reuptake inhibitor (SSRI), is one of the most widely prescribed worldwide. Although the effects of FLX on aquatic organisms are well documented, the molecular mechanisms underlying these effects remain insufficiently understood and are essential for a comprehensive assessment of its environmental impact. The present study investigated the molecular effects of FLX in the marine mussel Mytilus galloprovincialis. Mussels were exposed to a nominal concentration of FLX (3.1 µg/L) for 28 days with sampling on days 2, 7, 14, and 28. Molecular responses were characterized using a multi-omics approach. Transcriptomics, proteomics, and metabolomics were acquired from paired digestive gland samples (from the same individual) and subsequently integrated through data fusion modeling and pathway-enrichment analyses. Although molecular responses to FLX were relatively subtle, multi-omics integration revealed consistent modulation of pathways involved in cellular signaling, oxidative stress, energy metabolism, and MAPK pathways. These molecular responses were consistent with previously reported organism-level effects of FLX in mussels. Based on these findings, a putative Adverse Outcome Pathway (AOP) was proposed to link the molecular events identified in this study to individual effects previously reported in the literature. Overall, these findings highlight the value of multi-omics approaches for elucidating pharmaceutical effects in marine organisms and underscore the importance of integrating molecular data with organism-level observations to support AOP development.
SN - 0166-445X
ER -